Pages that link to "Q34197356"

The following pages link to Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy. (Q34197356):

Displaying 33 items.

• SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle (Q24318317) (← links)
• Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies (Q26782052) (← links)
• Adipogenesis (Q26828614) (← links)
• Regulation of epithelial-mesenchymal transition through SUMOylation of transcription factors (Q27010433) (← links)
• PIAS proteins: pleiotropic interactors associated with SUMO (Q28248545) (← links)
• Complex SUMO-1 regulation of cardiac transcription factor Nkx2-5 (Q28477049) (← links)
• TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation (Q28509337) (← links)
• Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation (Q30377831) (← links)
• PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes (Q30448407) (← links)
• A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics (Q33596988) (← links)
• The critical role of SENP1-mediated GATA2 deSUMOylation in promoting endothelial activation in graft arteriosclerosis (Q33770904) (← links)
• Sumoylation regulates interaction of FOG1 with C-terminal-binding protein (CTBP) (Q34107383) (← links)
• Modification of the erythroid transcription factor GATA-1 by SUMO-1. (Q34828184) (← links)
• GATA-2 mediated regulation of normal hematopoietic stem/progenitor cell function, myelodysplasia and myeloid leukemia (Q35871343) (← links)
• Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H. (Q35913673) (← links)
• The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs. (Q36225738) (← links)
• Role of the GATA family of transcription factors in endocrine development, function, and disease (Q36512426) (← links)
• SUMOylation inhibits SF-1 activity by reducing CDK7-mediated serine 203 phosphorylation. (Q37072165) (← links)
• SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. (Q37073920) (← links)
• Epigenetic control of complex loci during erythropoiesis (Q37087623) (← links)
• Sumoylation and regulation of cardiac gene expression (Q37097348) (← links)
• Protein Inhibitor of Activated STAT Y (PIASy) Regulates Insulin Secretion by Interacting with LIM Homeodomain Transcription Factor Isl1. (Q37522744) (← links)
• SUMOylation in carcinogenesis (Q37964361) (← links)
• SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene (Q39278637) (← links)
• The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51. (Q39768470) (← links)
• Sumoylation-dependent control of homotypic and heterotypic synergy by the Kruppel-type zinc finger protein ZBP-89. (Q40067075) (← links)
• PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis. (Q40536286) (← links)
• A small conserved surface in SUMO is the critical structural determinant of its transcriptional inhibitory properties. (Q41772583) (← links)
• FLI-1 functionally interacts with PIASxalpha, a member of the PIAS E3 SUMO ligase family. (Q46691163) (← links)
• Localization of GATA2 in the nuclear and cytoplasmic regions of ovine conceptuses (Q46846754) (← links)
• PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation. (Q55308600) (← links)
• Luminal cells GATA have it (Q79702490) (← links)
• Integrin αVβ5/Akt/Sp1 pathway participates in matrix stiffness-mediated effects on VEGFR2 upregulation in vascular endothelial cells (Q99241251) (← links)